CO6640331A2 - Tratamiento anti-envejecimiento de la piel - Google Patents

Tratamiento anti-envejecimiento de la piel

Info

Publication number
CO6640331A2
CO6640331A2 CO12235622A CO12235622A CO6640331A2 CO 6640331 A2 CO6640331 A2 CO 6640331A2 CO 12235622 A CO12235622 A CO 12235622A CO 12235622 A CO12235622 A CO 12235622A CO 6640331 A2 CO6640331 A2 CO 6640331A2
Authority
CO
Colombia
Prior art keywords
skin treatment
aging skin
cosmetically
skin
peptide
Prior art date
Application number
CO12235622A
Other languages
English (en)
Inventor
Puche Juan Cebrain
Domenech Nuria Alminana
Gonzalez Raquel Delgado
Original Assignee
Lipotec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lipotec Sa filed Critical Lipotec Sa
Publication of CO6640331A2 publication Critical patent/CO6640331A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/08—Clostridium, e.g. Clostridium tetani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/88—Two- or multipart kits
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/91—Injection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02—Preparations containing skin colorants, e.g. pigments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02—Preparations containing skin colorants, e.g. pigments
    • A61Q1/04—Preparations containing skin colorants, e.g. pigments for lips
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02—Preparations containing skin colorants, e.g. pigments
    • A61Q1/10—Preparations containing skin colorants, e.g. pigments for eyes, e.g. eyeliner, mascara
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/14—Preparations for removing make-up

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biotechnology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)

Abstract

Un método para el tratamiento anti-envejecimiento de la piel que comprende administrar toxina botulínica a un área de la piel del rostro y/o cuello, en combinación con la administración de una composición cosmética o farmacéutica que comprende una cantidad cosméticamente o farmacéuticamente efectiva de al menos un péptido derivado de la proteína SNAP25 y/o al menos un péptido derivado de encefalina y al menos un excipiente o adyuvante cosméticamente o farmacéuticamente aceptable.
CO12235622A 2010-06-09 2012-12-28 Tratamiento anti-envejecimiento de la piel CO6640331A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12/797,222 US20110305735A1 (en) 2010-06-09 2010-06-09 Skin antiaging treatment

Publications (1)

Publication Number Publication Date
CO6640331A2 true CO6640331A2 (es) 2013-03-22

Family

ID=44627143

Family Applications (1)

Application Number Title Priority Date Filing Date
CO12235622A CO6640331A2 (es) 2010-06-09 2012-12-28 Tratamiento anti-envejecimiento de la piel

Country Status (13)

Country Link
US (1) US20110305735A1 (es)
EP (1) EP2579952B1 (es)
JP (2) JP6306885B2 (es)
KR (4) KR20190135555A (es)
CN (1) CN103096980B (es)
AU (1) AU2011264125B2 (es)
BR (1) BR112012031117B1 (es)
CA (1) CA2801961C (es)
CO (1) CO6640331A2 (es)
ES (1) ES2654342T3 (es)
MX (1) MX342853B (es)
WO (1) WO2011154126A2 (es)
ZA (1) ZA201209484B (es)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9486408B2 (en) * 2005-12-01 2016-11-08 University Of Massachusetts Lowell Botulinum nanoemulsions
WO2011041483A2 (en) * 2009-09-30 2011-04-07 Toxcure, Inc. Use of botulinum neurotoxin to treat substance addictions
MX356540B (es) * 2011-05-10 2018-06-01 Mary Kay Inc Composiciones cosmeticas.
JP5889220B2 (ja) * 2012-03-30 2016-03-22 富士フイルム株式会社 水性分散組成物
EP2649984A1 (en) * 2012-04-13 2013-10-16 Lipotec, S.A. Compounds which inhibit neuronal exocytosis
US8758783B1 (en) 2012-12-20 2014-06-24 L'oreal Water-in-oil emulsion comprising pigments in the water phase
RU2524663C1 (ru) * 2013-04-26 2014-07-27 Общество с ограниченной ответственностью "ДЖИ-Групп" Комплексное косметическое средство
CN103505377B (zh) * 2013-09-11 2015-06-03 深圳市维琪医药研发有限公司 一种具皮肤活性的多肽组合物
WO2015063613A2 (en) 2013-11-01 2015-05-07 Spherium Biomed S.L. Inclusion bodies for transdermal delivery of therapeutic and cosmetic agents
CN103637925B (zh) * 2013-12-03 2015-09-30 广州健坤生物科技有限公司 γ-氨基丁酸(GABA)和一种小肽在化妆品中的联合应用
CN103641888B (zh) * 2013-12-03 2015-08-12 广州健坤生物科技有限公司 一种多功能新型小肽、包含该肽的组合物及其应用
CN104000744A (zh) * 2014-06-12 2014-08-27 金玲 一种改善肌肤新陈代谢并能延缓衰老的美容用液及其生产方法
JP6643324B2 (ja) 2014-09-02 2020-02-12 アメリカン シルヴァー リミテッド ライアビリティ カンパニー ボツリヌス毒素及びコロイド状銀粒子
WO2016167545A1 (ko) * 2015-04-13 2016-10-20 주식회사 엘지생활건강 신경전달물질의 배출을 조절하는 성분이 포함된 용해성 마이크로니들
KR102203633B1 (ko) * 2015-04-14 2021-01-15 주식회사 엘지생활건강 칼슘채널 차단제 전달용 용해성 미세바늘
CN107427474A (zh) 2015-04-13 2017-12-01 株式会社Lg生活健康 含有调节神经递质释放的成分的可溶性微针
KR101843065B1 (ko) * 2016-01-06 2018-03-28 바이오스펙트럼 주식회사 카노신, 대두 펩타이드 및 천심련 추출물을 포함하는 항노화용 조성물
US10493020B2 (en) 2016-04-14 2019-12-03 The Procter & Gamble Company Method of improving the appearance of periorbital dyschromia
BR112018074202B1 (pt) * 2016-05-24 2022-08-02 Natura Cosméticos S.A Composição cosmética antissinais, kit de composições e método para tratamento cosmético da pele
KR101895906B1 (ko) * 2016-07-07 2018-10-04 주식회사 한국화장품제조 펩타이드 리포좀을 포함하는 스틱형 화장료 조성물
US20180133131A1 (en) * 2016-11-14 2018-05-17 Ariix Skin rejuvenating compositions
WO2018093465A1 (en) 2016-11-21 2018-05-24 Eirion Therapeutics, Inc. Transdermal delivery of large agents
EP3585488A1 (en) * 2017-02-24 2020-01-01 Lipotrue, S.L. Peptides and compositions for use in cosmetics
US10258556B2 (en) * 2017-06-19 2019-04-16 Yu-Chun Liu Anti-aging peptide, its composition and method of using the same
KR102311724B1 (ko) * 2017-09-15 2021-10-13 (주)아모레퍼시픽 슈도알터로모나스 펩티도라이티카의 배양물 또는 이의 추출물을 포함하는 피부 미백용 조성물
CN107693391A (zh) * 2017-11-21 2018-02-16 上海合轩品牌管理有限公司 一种抗皱眼霜及其制备方法
KR102041561B1 (ko) * 2018-02-23 2019-11-06 주식회사 메디쿼터스 미세먼지 차단용 피부화장료 조성물 및 겔 조성물
EP3843777A4 (en) * 2018-08-28 2022-05-04 Ira Sanders THERAPEUTICS FOR THE SKIN
CN109293737B (zh) * 2018-09-27 2020-10-27 华南理工大学 一种抗皮肤衰老的四肽及其用途
KR102139472B1 (ko) * 2018-10-31 2020-07-30 에이앤펩주식회사 기능성 펩타이드와 발효물을 포함하는 피부노화 개선용 조성물
JP7378839B2 (ja) * 2018-12-26 2023-11-14 スキンメドカンパニーリミテッド アセチルコリン受容体阻害ペプチド及びその用途
CN111904881B (zh) * 2020-08-11 2023-05-23 上海科颜生物科技有限公司 一种抗衰紧致组合物及其制备方法和应用
CN113307851B (zh) * 2021-06-11 2022-04-29 珠海医美企业管理有限公司 一种改善皮肤生理特性的活性肽与间充质干细胞外泌体在药品或化妆品中的应用
CN113577364A (zh) * 2021-08-13 2021-11-02 常州谙美生物科技有限公司 一种用于晒后修复的医用敷料
CN115400043B (zh) * 2022-08-04 2023-10-31 广州环亚化妆品科技股份有限公司 一种抗皱组合物及其制备方法和在化妆品中的应用
CN116003518B (zh) * 2023-01-10 2023-09-29 深圳市维琪科技股份有限公司 经设计的肽及其组合物和用途
CN116747148B (zh) * 2023-07-24 2024-10-01 山东福瑞达生物股份有限公司 一种适用于敏感肌的抗衰化妆品组合物
CN117297997B (zh) * 2023-11-28 2024-03-19 杭州湃肽生化科技有限公司 一种高效紧肤多肽组合物及其产品应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69529043T2 (de) 1994-09-30 2003-05-08 L'oreal S.A., Paris Verwendung von einem Agonisten eines mit einem Chloridkanal assozierten Rezeptors zur Behandlung von Hautfalten
AU2334897A (en) 1996-03-18 1997-10-10 Regents Of The University Of California, The Peptide inhibitors of neurotransmitter secretion by neuronal cells
FR2746641B1 (fr) 1996-03-27 1998-06-05 Oreal Utilisation d'un extrait d'au moins une iridacee dans le traitement des rides
ES2160485B1 (es) * 1999-04-23 2002-05-16 Lipotec Sa Peptidos inhibidores de la exocitosis neuronal, composiciones cosmeticas y farmaceuticas que los contienen.
FR2798590B1 (fr) 1999-09-21 2001-11-30 Oreal Utilisation de l'alverine pour diminuer les rides
US7780967B2 (en) * 2000-02-08 2010-08-24 Allergan, Inc. Reduced toxicity Clostridial toxin pharmaceutical compositions
FR2809005B1 (fr) 2000-05-18 2002-12-27 Oreal Utilisation du manganese dans le traitement des rides
FR2846885B1 (fr) 2002-11-13 2004-12-24 Oreal Utilisation d'une association de composants a effet synergique inhibiteur de canaux calciques pour prevenir ou traiter les ridules
ES2259928B1 (es) * 2005-04-08 2007-11-01 Lipotec, S.A. Composicion cosmetica o dermofarmaceutica que comprende peptidos derivados de encefalinas para reducir y/o eliminar arrugas faciales.
ES2322882B1 (es) * 2006-10-25 2010-04-22 Lipotec Sa Peptidos inhibidores de la exocitosis neuronal.

Also Published As

Publication number Publication date
WO2011154126A2 (en) 2011-12-15
ZA201209484B (en) 2014-02-26
ES2654342T3 (es) 2018-02-13
JP6306885B2 (ja) 2018-04-04
KR20190135555A (ko) 2019-12-06
MX2012014389A (es) 2013-01-29
JP2018058842A (ja) 2018-04-12
WO2011154126A3 (en) 2012-07-26
MX342853B (es) 2016-10-14
CA2801961C (en) 2018-11-20
BR112012031117A2 (pt) 2016-08-23
US20110305735A1 (en) 2011-12-15
CA2801961A1 (en) 2011-12-15
JP2013533226A (ja) 2013-08-22
KR20210090731A (ko) 2021-07-20
BR112012031117B1 (pt) 2018-01-16
EP2579952B1 (en) 2017-11-08
EP2579952A2 (en) 2013-04-17
AU2011264125B2 (en) 2015-03-19
KR20180083958A (ko) 2018-07-23
AU2011264125A1 (en) 2012-12-20
KR20130135819A (ko) 2013-12-11
CN103096980A (zh) 2013-05-08
CN103096980B (zh) 2018-02-09

Similar Documents

Publication Publication Date Title
CO6640331A2 (es) Tratamiento anti-envejecimiento de la piel
MX353165B (es) Vacunas contra el cancer cerebral basadas en peptido alfa 2 del receptor de interleucina 13.
MX2019004314A (es) Composición de apósito tópico para el tratamiento de tejido cutáneo dañado.
AR088044A1 (es) Proteinas de fusion para tratar trastornos metabolicos
BR112017007892A2 (pt) composição, e, preparação injetável.
MX2018005256A (es) Formulaciones inyectables de toxina botulinica y metodos de uso de las mismas que tienen efecto terapautico o cosmetico de larga duracion.
WO2015183963A3 (en) Therapeutic compositions including redox-active parabenzoquinones and uses thereof
AR069806A1 (es) Uso de un componente neurotoxico del complejo de toxina botulinica creada por la bacteria clostridium botulinum para reducir o evitar efectos colaterales
CL2012001029A1 (es) Tetrapeptidos que promueven el aumento de hsp70, sus estereoisomeros, mezclas de los mismos y/o sus sales cosmetica o farmaceuticamente aceptables; composicion cosmetica o farmaceutica que comprende al menos uno de dichos peptidos; y usos de los mismos para el cuidado de la piel, mucosa y/o cabello.
MX2011010859A (es) Peptidos utiles en el tratamiento y/o cuidado de la piel y/o cabello y su uso en composiciones cosmeticas o farmaceuticas.
EP2528934A4 (en) AROMATIC-CATIONIC PEPTIDES AND USES THEREOF
BR112016003358A2 (pt) método para aumentar a expressão de proteínas codificadas por rna
ECSP12011803A (es) Polipéptidos inmunomoduladores derivados de la il-2 y su uso terapéutico en cáncer y en infecciones crónicas
NZ700623A (en) Botulinum toxin dosage regimen for chronic migraine prophylaxis
EP3501532A3 (en) Therapeutic compositions including frataxin, lactoferrin, and mitochondrial energy generating enzymes, and uses thereof
BR112012029975A2 (pt) peptídeo como medicamento, em particular para o tratamento do câncer.
MX2013012545A (es) Preparacion liofilizada de dipeptidos citotoxicos.
MA40057A (fr) Traitement thérapeutique de maladie cutanée au moyen de micro-organismes cutanés commensaux recombinants
WO2014165607A3 (en) Aromatic-cationic peptide formulations, compositions and methods of use
BR112015009280A2 (pt) preparações liofilizadas de melfalana flufenamida
BRPI0922789A2 (pt) peptídeo de ligação de albumina intermediador para reconhecimento de doença
AR100134A1 (es) Métodos y composiciones de administración tópica para el cuidado de la piel
UA111599C2 (uk) Композиція каспофунгіну
MY190257A (en) Optimised subcutaneous therapeutic agents
MX2022010186A (es) Neurotoxinas botulinas para uso en terapia.

Legal Events

Date Code Title Description
FA Application withdrawn